Abstract New concepts for substrate-and transition-state-derived sialyltransferase inhibitors are deduced from enzymatic sialyl transfer with CMP-Neu5Ac as donor substrate. On this basis, transition-state analogue (R)-1 was synthesized, which inhibits α (2–6)- sialyltransferase from rat liver, an important lead for further investigations.